| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. | SVP, CFO and Treasurer | Common Stock | 519,300 | $872,424 | $1.68 | 31 Jan 2024 | Direct |
| Akebia Therapeutics, Inc. | SVP, CFO and Treasurer | Stock Option (Right to buy) | 224,000 | 31 Jan 2024 | Direct | ||
| Pear Therapeutics, Inc. | VP, Chief Accounting Officer | Restricted Stock Units | 40,000 | 16 Feb 2023 | Direct |